Skip to content

A multicenter study on warfarin use and optimal anticoagulation levels for prevention of cardiogenic embolism in Japanese patients with atrial fibrillation: J-RHYTHM Registry

A multicenter study on warfarin use and optimal anticoagulation levels for prevention of cardiogenic embolism in Japanese patients with atrial fibrillation: J-RHYTHM Registry - J-RHYTHM Registry

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000001569
Enrollment
6000
Registered
2009-01-05
Start date
2009-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

None listed

Sponsors

The Japanese Society of Electrocardiology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: all patient with atrial fibrillation accepted the informal consent

Exclusion criteria

Exclusion criteria: inadequate patients judged by their physician

Design outcomes

Primary

MeasureTime frame
Investigation of clinical background at the development of following clinical event; symptomatic cerebral infarction, systemic embolism, major bleeding, all cause of death Optimal PT-INR for Japanese patients with atrial fibrillation

Secondary

MeasureTime frame
Preventive effects of various medications including warfarin, antithrombotics drugs and others for the treatment of Japanese patients with atrial fibrillation

Countries

Japan

Contacts

Public ContactHirotsugu Atarashi

Nippon Medical School Tama-Nagayama Hospital Internal Medicine

jr-registry@nms.ac.jp042-371-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026